Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?

It's hard to overstate just how successful the expansions of new diabetes treatments into the weight management arena have been for the companies that sell them. In one striking example, the market capitalization of Novo Nordisk (NYSE: NVO), formerly a relatively obscure drugmaker that until…#novonordisk #nvo #tesla #elililly #lly #zepbound #amazon #amazonpharmacy #mounjaro #glp1
Source: Reuters: Health - Category: Consumer Health News Source Type: news